Morocco's Sothema to produce China's Sinopharm vaccine

Moroccan pharmaceutical firm Sothema will soon start production of 5 million doses a month of China's Sinopharm COVID-19 vaccine in the North African country, state news agency MAP reported on Monday. The announcement was made at a ceremony chaired by King Mohammed VI during which the Moroccan government, Sinopharm and Sothema, whose formal name is Société Thérapeutique Marocaine, also signed deals to produce the vaccine in Morocco, which has a population of about 36 million.